摘要
目的探讨单硝酸异山梨酯联合呋褰米治疗慢性心力衰竭的临床疗效。方法选取2013年2月至2014年8月来我院治疗的72例慢性心力衰竭患者,随机分为对照组和观察组,每组36例,列照组的患者给予常规治疗,观察组的患者在常规治疗的同时给严单硝酸异山梨酯联合吠塞米进行治疗。比较嘶组的临床疗效。结果观察组的总有效率为94.4%,对照组的总有效率为69.4%。观察组的临床总有效率明姓高于对照组(P〈0.05);并且观察组的各项躲测指标改善情况均明镀优于对照组,组间差异具有统计学意义(P〈0.05);观察组的不良反应发生率也明娃低于对照组(P〈0.05)。结论单硝酸异山梨酯联合呋塞米治疗慢性心力衰竭的临床疗效艟著,有利于改善心袭患者的预后情况,值得广泛推广于应用。
Objective to investigate the isosorbide mononitrate joint Sammy therapy the clinical curative effect of chronic heart fail- ure. Methods from February 2013 to August 2013 treated 72 cases of patients with chronic heart failure, were randomly divided into control group and observation group, 36 cases in each group, control group were given routine therapy, observation group of patients in the conventional treatment at the same time give isosorbide mononitrate joint, Sammy for therapy comparison of two groups of clini cal eurative effect. Results the total effective rate was 94. 4%, the observation group in the control group total effective rate was 69.4 %, the clinical total effective rate of observation group was obviously higher than that of control group (P〈0.05) ; And improve the monitoring indicators in observation group were obviously superior to control group, the differences between the groups with statis- tical significance (P〈0. 05) ; Rate of adverse reaction of observation group was obviously lower than the control group (P〈0.05). Conclusion the isosorhide mononitrate joint Sammy therapy of chronic heart failure clinical curative effect is distinct, to improve the prognosis of patients with heart failure, is worth popularizing widely applied.
出处
《检验医学》
CAS
2016年第B11期290-291,共2页
Laboratory Medicine
关键词
单硝酸异山梨酯
吠塞米
慢性心力衰竭
临床疗效
isosorbide mononitrate
Cefuroxime Sammy
Chronic heart failure
Clinical curative effect